MACROGENICS INC — Director's Dealing 2013

Oct 9, 2013

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: MACROGENICS INC (MGNX)
CIK: 0001125345
Period of Report: 2013-10-09

Reporting Person: Koenig Scott (Director, President and CEO)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	53265	Direct
Common Stock	641209	Indirect
Common Stock	53265	Indirect

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Option (right to buy)	$.94	2017-01-06	Common Stock (62205)		Direct
Stock Option (right to buy)	$.94	2017-11-15	Common Stock (79898)		Direct
Stock Option (right to buy)	$.94	2017-11-15	Common Stock (79898)		Direct
Stock Option (right to buy)	$.94	2019-01-10	Common Stock (11652)		Direct
Stock Option (right to buy)	$.94	2019-01-10	Common Stock (14981)		Direct
Stock Option (right to buy)	$.94	2019-01-10	Common Stock (59591)		Direct
Stock Option (right to buy)	$.94	2019-01-10	Common Stock (20307)		Direct
Stock Option (right to buy)	$.94	2020-01-09	Common Stock (5493)		Direct
Stock Option (right to buy)	$.94	2020-01-09	Common Stock (2497)		Direct
Stock Option (right to buy)	$.94	2022-03-13	Common Stock (133164)		Direct
Stock Option (right to buy)	$1.50	2023-01-05	Common Stock (53265)		Direct

Footnotes

F1: Reflects a 1-for-18.7739 reverse split of our common stock effected on September 26, 2013.

F2: 12.5% of the shares underlying the option are exercisable beginning on the six month anniversary of the vesting start date, and an additional 6.25% of the shares underlying the option become exercisable on the first day of each three month anniversary thereafter.